E, M., L, I., I, O., J, U., M, R. d. G., X, B., . . . JM, B. (2026). Statins halt polycystic liver disease by reprogramming metabolism and normalizing mitochondrial bioenergetics in cystic cholangiocytes. Hepatology (Baltimore, Md.). https://doi.org/10.1097/HEP.0000000000001711
Chicago Style (17th ed.) CitationE, Markaide, et al. "Statins Halt Polycystic Liver Disease by Reprogramming Metabolism and Normalizing Mitochondrial Bioenergetics in Cystic Cholangiocytes." Hepatology (Baltimore, Md.) 2026. https://doi.org/10.1097/HEP.0000000000001711.
MLA (9th ed.) CitationE, Markaide, et al. "Statins Halt Polycystic Liver Disease by Reprogramming Metabolism and Normalizing Mitochondrial Bioenergetics in Cystic Cholangiocytes." Hepatology (Baltimore, Md.), 2026, https://doi.org/10.1097/HEP.0000000000001711.